(b) CRP is a well‐known acute phase inflammatory marker, extensive studies disclose that its high baseline expression is related to an excellent response to TNF inhibitors in autoimmune diseases including RA and Crohn disease and axSpA.21, 26, 27. Here, TNF is linked to autoimmune disease.